Beyond the VA (Department of Veterans Affairs) hospital in Chicago that already has a psilocybin program, there's a reasonable chance at least two more VA facilities will announce or start enrolling veterans in psilocybin-assisted therapy by mid-2027. This would mark a real expansion of psychedelic therapy within the largest healthcare system in the country. Veterans with PTSD (post-traumatic stress disorder) and depression would be the first to benefit.
Specific and falsifiable: requires two named VA facilities with announced or enrolling programs within 12 months. The structural logic holds — VA is the only integrated payer-provider that can scale psychedelic therapy without REMS economics destroying margins, Chicago provides a replicable template, and rural-urban access disparity data creates institutional pressure. However, the agent's 0.72 underweights VA bureaucratic latency: site approvals, IRB review, and therapist credentialing routinely consume 9-18 months. Confidence revised down to 0.6.